Recombinant anti-CD30 antibodies and uses thereof

Details for Australian Patent Application No. 2002236518 (hide)

Owner Seattle Genetics, Inc

Inventors Francisco, Joseph A.; Wahl, Alan F.; Siegall, Clay B; Risdon, Grant

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002236518

PCT Pub. Number WO02/43661

Priority 09/724,406 28.11.00 US

Filing date 28 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 26 October 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 October 2006 Application Accepted

  Published as AU-B-2002236518

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236519-Methods for the prevention and treatment of cancer using anti-C3B(i) antibodies

2002236517